The idea that the human body can repair itself in the same way that nature repairs a plant or a tree does not seem so far-fetched. What was once considered science fiction is now becoming increasingly closer to reality thanks to advances in biology, biotechnology and medicine. This innovative field, which seeks to restore functionality to damaged organs and tissues, is known as regenerative medicine.
With each discovery, regenerative medicine opens new doors to treatments that once seemed impossible, offering the possibility of improving the health of millions of people around the world.
At Ambar Lab, we contribute to this progress by offering more than 3,000 laboratory tests, support in managing your business, and the development of new projects. On this occasion, we analyse what regenerative medicine is, what its most relevant applications are, and much more.
What is regenerative medicine and what is it used for?
Regenerative medicine is a branch of biomedicine that focuses on repairing, replacing or regenerating cells, tissues and organs that have been damaged by disease, injury or degenerative processes. Its purpose is not only to alleviate symptoms, but to restore biological function in a lasting way.
The discipline combines techniques from different fields such as tissue engineering, cell therapy, gene therapy, and the application of biomolecules. All of these work individually or together to activate the human body’s self-healing capacity. Let us take a closer look at their specific functions.
What is regenerative medicine used for?
Treatment of serious illnesses
Complex conditions such as heart attacks, spinal cord injuries, multiple sclerosis and type 1 diabetes are the subject of clinical trials and research projects. For example, some hospitals have already performed stem cell implants in patients with heart failure to improve heart function and reduce the risk of future complications.
Repair of musculoskeletal injuries
Joint wear and sports injuries are among the most common applications in this field. Platelet-rich plasma injections or the use of mesenchymal stem cells help regenerate cartilage, tendons and muscles, reducing pain and speeding up recovery.
Aesthetic and wellbeing improvements
Facial rejuvenation using cell therapies or growth factors, as well as treatments for alopecia, are now common procedures in specialised clinics. Their appeal lies in the fact that they offer more natural results than traditional surgical methods.
Ageing mitigation
Research is also focused on slowing down age-related deterioration. Therapies are being explored to eliminate senescent cells (those that have lost their ability to divide and contribute to ageing) and stimulate cell regeneration, with the aim of prolonging vitality and improving quality of life.
What does a regenerative medicine practitioner do?
A doctor specialising in regenerative medicine acts as a bridge between basic science and clinical practice. Their work begins with a thorough analysis of each patient and extends to the supervision of the regenerative process.
- Personalised diagnosis: analyses damage to tissues, organs or systems, and determines the most appropriate treatment based on the patient’s condition and profile.
- Application of therapies: uses range from stem cells to tissue engineering or growth factors, depending on regeneration needs.
- Continuous monitoring: monitors the healing process, vascularisation and tissue remodelling, and adjusts therapy if necessary.
- Prevention and healthy ageing: recommends strategies to help slow down biological ageing and prevent chronic diseases.
- Management of complex cases: treats patients who have not found a solution in conventional medicine, such as those with chronic injuries, degenerative diseases, or organ failure.
In daily practice, their role is essential in ensuring that treatments are safe and tailored to each patient.
What are the four regenerative medicines?
Regenerative medicine is based on four main pillars that work in a complementary manner:
Cell therapy
It consists of using living cells to regenerate tissues or organs. Embryonic, adult or induced pluripotent stem cells (iPS) are used. For example, leukaemia patients treated with bone marrow transplants, where haematopoietic stem cells regenerate the blood system.
Tissue engineering
It combines cells, biomaterials and technology to create biological structures. The manufacture of artificial skin for severe burns is one of the most established applications: cells are cultivated in the laboratory on biocompatible supports, which are then implanted in the patient.
Gene therapy
It acts directly on a cell’s genes to correct mutations or stimulate regenerative processes. According to the Innovative Genomics Institute, CRISPR-based therapy called Casgevy has been approved in the US and Europe since 2023-2024 for the treatment of sickle cell anaemia and beta thalassaemia.
Growth factors and cytokines
They are proteins and signalling molecules that guide cell regeneration. Platelet-rich plasma (PRP) is a clear example in traumatology and aesthetic medicine, used to regenerate soft tissue and improve healing.
Benefits and potential of regenerative medicine
Regenerative medicine has the potential to transform the way we understand health:
- Less reliance on transplants: it could reduce waiting lists by offering alternatives for regenerating damaged organs and tissues.
- Better quality of life: by regaining lost functions, patients can return to their daily lives with greater independence.
- Long-lasting and natural treatments: therapies seek to rely on the body’s own biological mechanisms, thereby reducing side effects.
- Advances in personalised medicine: by adapting to each patient, therapies are more effective than standard treatments.
What challenges does it present?
Although the potential is enormous, regenerative medicine faces some obstacles that limit its widespread application:
High costs
The laboratory techniques required to cultivate stem cells, generate tissues under sterile conditions, or apply gene therapies require sophisticated equipment and highly qualified personnel.
Furthermore, manufacturing and quality control processes are lengthy and costly, which increases the final price for patients. As a result, accessibility is limited to certain medical centres and people with high purchasing power, which opens up a debate on the need for public funding systems and collaborations with industry to reduce costs.
Ethical and legal barriers
The use of embryonic stem cells has been the subject of debate since its inception, as it raises ethical questions about the origin and manipulation of this type of cell. On the other hand, gene therapy and genetic editing with tools such as CRISPR generate discussions about the limits that should be placed on the modification of human DNA.
At the legal level, each country establishes different regulations, which slows down the approval of therapies and creates uncertainty for researchers, doctors, and patients. Although Spain has advanced regulations in bioethics, there are still limitations to conducting some trials.
Medical risks
Although regenerative therapies have shown promising results, they still present risks that must be carefully controlled. These include immune rejection, which can occur when the body does not accept the transplanted cells, and unwanted mutations, which could lead to tumours or other serious complications.
Another challenge is the lack of long-term studies: although certain treatments work in the first few months, it is not always clear how the results will evolve over several years. For this reason, doctors must maintain close supervision and propose these treatments within controlled protocols.
Need for larger clinical trials
Most regenerative therapies are still in the experimental phase, which limits their availability in clinical practice. Although there have been very positive results in small groups of patients, it is essential to conduct larger and longer clinical trials to confirm their safety and efficacy in different populations.
In addition, the approval processes by regulatory bodies such as the European Medicines Agency (EMA) are long and demanding.
The health revolution has already begun
Regenerative medicine represents a profound change in the way we conceive of health and longevity. Over time, it will enable us to repair organs, regenerate tissues and offer solutions to diseases that were previously incurable. Although the challenges are significant, its development heralds a future where repairing the human body will be a reality within the reach of millions of people.
At Ambar Lab, we are committed to this future. In addition to covering everything from the most basic to the most advanced analyses, we carry out tailor-made R&D projects with national and international clients, working with your business and offering you all our knowledge to solve your challenges.
Would you like to learn how innovation can transform your health or your business? Contact us and discover everything we can do for you.
